BidaskClub Downgrades RTI Surgical (RTIX) to Sell
BidaskClub cut shares of RTI Surgical (NASDAQ:RTIX) from a hold rating to a sell rating in a report issued on Thursday morning.
RTI Surgical (RTIX) remained flat at $$4.65 on Thursday. 16,886 shares of the company traded hands, compared to its average volume of 140,484. RTI Surgical has a 1-year low of $3.58 and a 1-year high of $6.00. The company has a market capitalization of $284.39, a price-to-earnings ratio of -468.00, a PEG ratio of 2.07 and a beta of 1.69. The company has a debt-to-equity ratio of 0.25, a current ratio of 3.34 and a quick ratio of 1.21.
RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings data on Thursday, March 1st. The medical equipment provider reported $0.03 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.04 by ($0.01). RTI Surgical had a net margin of 2.24% and a return on equity of 2.93%. The business had revenue of $70.82 million during the quarter, compared to analyst estimates of $70.16 million. equities analysts forecast that RTI Surgical will post 0.15 earnings per share for the current year.
About RTI Surgical
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.